Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/4648
Title: 3-O-(E)-p-coumaroyl tormentic acid from Eriobotrya japonica leaves induces caspase-dependent apoptotic cell death in human leukemia cell line
Authors: Kikuchi T.
Akazawa H.
Tabata K.
Manosroi A.
Manosroi J.
Suzuki T.
Akihisa T.
Issue Date: 2011
Abstract: Eleven triterpene acids, 1-11, isolated from the leaves of Eriobotrya japonica, were evaluated for inhibition of DNA topoisomerase (Topo) I and cytotoxicity against human leukemia (HL60) and melanoma cell lines (CRL1579). Among the compounds tested, four compounds, d-oleanolic acid (4), ursolic acid (5), 3-O-(E)-p-coumaroyl tormentic acid (8), and betulinic acid (10), exhibited potent Topo I inhibitory activity (IC50 20.3-36.5 μM) and cytotoxicity against HL60 (EC50 5.0-8.1 μM). Upon assessing the apoptosis-inducing activity in. HL60 cells, compound 8 exhibited induction of apoptosis detected by the observation of DNA fragmentation and membrane phospholipid exposure in flow cytometry. Western blot analysis showed that compound 8 markedly reduced the levels of procaspases-3 and 9, while being increased the levels of cleaved caspases-3 and 9. On the other hand, compound 8 exerted almost no influence on the expression of caspase-8. In addition, compound 8 increased significantly Bax/Bcl-2 ratio and activated caspase-2. These results suggested that compound 8 induced apoptotic cell death in HL60 via mainly mitochondrial pathway by, at least in part, Topo I inhibition. Therefore, compound 8 may be promising lead compound for developing an effective drug for treatment of leukemia. © 2011 Pharmaceutical Society of Japan.
URI: http://www.scopus.com/inward/record.url?eid=2-s2.0-79952412542&partnerID=40&md5=080bcb04a6b6a10d5da0e2fa8dcc87c9
http://cmuir.cmu.ac.th/handle/6653943832/4648
ISSN: 92363
Appears in Collections:PHARMACY: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.